4528 — Ono Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapContrarian

Annual income statement for Ono Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	288,634	292,420	309,284	361,361	447,187
Cost of Revenue
Gross Profit	204,805	213,357	223,711	267,850	337,125
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	226,624	214,929	210,809	257,921	305,224
Operating Profit	62,010	77,491	98,475	103,440	141,963
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	65,141	79,696	100,890	105,025	143,532
Provision for Income Taxes
Net Income After Taxes	51,679	59,888	75,498	80,685	112,913
Minority Interest
Net Income Before Extraordinary Items
Net Income	51,539	59,704	75,426	80,519	112,723
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	51,539	59,704	75,425	80,519	112,708
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	102	118	151	173	243
Dividends per Share